Clinical Trial Update: ABSORB PHYSIOLOGY Clinical Investigation [NA]

View source ↗

Summary

Abbott's ABSORB Physiology clinical investigation for coronary artery disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Absorb Bioresorbable Vascular Scaffold (ABSORB Physiology) (bioresorbable vascular scaffold)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | NA | Status: TERMINATED